Clene Inc. - CLNN

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$12.11M

QoQ value delta ($000)

+$751K (+6.61%)

Implied price effect (QoQ)

-14.53%

Total shares

2,416,546

QoQ shares delta

+479,200 (+24.73%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 29 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Boxer Capital Management, LLC	2,354	477,515	0.31%
SymBiosis Capital Partners, LLC	2,125	431,094	4.03%
VANGUARD CAPITAL MANAGEMENT LLC	1,519	308,230	0.0%
SCOGGIN MANAGEMENT LP	1,479	300,000	0.14%
VANGUARD GROUP INC	1,308	222,909	0.0%
Ensign Peak Advisors, Inc	1,271	257,872	0.0%
GEODE CAPITAL MANAGEMENT, LLC	473	95,874	0.0%
Lunt Capital Management, Inc.	257	52,260	0.1%
PEAK6 LLC	246	50,012	0.0%
VANGUARD FIDUCIARY TRUST CO	215	43,715	0.0%
PARSONS CAPITAL MANAGEMENT INC/RI	183	37,243	0.01%
BlackRock, Inc.	166	33,799	0.0%
STATE STREET CORP	146	29,801	0.0%
MORGAN STANLEY	97	19,832	0.0%
NORTHERN TRUST CORP	79	16,143	0.0%
PENN DAVIS MCFARLAND INC	54	11,000	0.01%
WELLS FARGO & COMPANY/MN	29	5,927	0.0%
Vanguard Global Advisers, LLC	27	5,609	0.0%
JONES FINANCIAL COMPANIES LLLP	23	5,000	0.0%
UBS Group AG	19	3,977	0.0%
PNC FINANCIAL SERVICES GROUP, INC.	13	2,735	0.0%
Atlantic Private Wealth, LLC	10	2,205	0.01%
OSAIC HOLDINGS, INC.	9	1,926	0.0%
GROUP ONE TRADING LLC	3	686	0.0%
Arax Advisory Partners	2	570	0.0%